Stock 4102 YUNG ZIP CHEMICAL IND. CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Yung Zip Chemical Ind. Co., Ltd.

Equities

4102

TW0004102009

Pharmaceuticals

End-of-day quote Taipei Exchange
Other stock markets
 18:00:00 2024-05-30 EDT 		5-day change 1st Jan Change
35.65 TWD +0.85% Intraday chart for Yung Zip Chemical Ind. Co., Ltd. +0.85% -10.20%
05-15 Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-14 Yung Zip Chemical Ind. Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 586.9 694.9 1,102 826.3 1,528 1,682
Enterprise Value (EV) 1 621.7 718.5 1,307 1,001 1,598 1,710
P/E ratio -39.2 x 22.2 x 36.1 x 139 x 21.8 x 27 x
Yield - - 0.38% 0.51% 2.22% 2.02%
Capitalization / Revenue 1.64 x 1.67 x 2.38 x 1.73 x 2.69 x 3.01 x
EV / Revenue 1.74 x 1.72 x 2.82 x 2.1 x 2.82 x 3.06 x
EV / EBITDA 22.1 x 12 x 19.8 x 21.5 x 18.6 x 19.1 x
EV / FCF -1,604 x 475 x -127 x 24.6 x 48.5 x 35.8 x
FCF Yield -0.06% 0.21% -0.79% 4.06% 2.06% 2.79%
Price to Book 1.32 x 1.39 x 2.15 x 1.61 x 2.49 x 2.65 x
Nbr of stocks (in thousands) 42,373 42,373 42,373 42,373 42,373 42,373
Reference price 2 13.85 16.40 26.00 19.50 36.05 39.70
Announcement Date 3/29/19 3/27/20 3/23/21 3/7/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 357.1 416.8 463.2 477.6 567.3 559.2
EBITDA 1 28.07 60.12 65.9 46.47 85.94 89.63
EBIT 1 -21.82 21.92 29.41 7.215 48.71 55.98
Operating Margin -6.11% 5.26% 6.35% 1.51% 8.59% 10.01%
Earnings before Tax (EBT) 1 -16.84 31.32 28.36 6.806 75.56 67.74
Net income 1 -14.96 31.32 30.74 6.004 69.99 62.51
Net margin -4.19% 7.51% 6.64% 1.26% 12.34% 11.18%
EPS 2 -0.3530 0.7391 0.7200 0.1400 1.650 1.470
Free Cash Flow 1 -0.3875 1.513 -10.26 40.68 32.93 47.74
FCF margin -0.11% 0.36% -2.22% 8.52% 5.81% 8.54%
FCF Conversion (EBITDA) - 2.52% - 87.54% 38.32% 53.26%
FCF Conversion (Net income) - 4.83% - 677.49% 47.05% 76.38%
Dividend per Share - - 0.1000 0.1000 0.8000 0.8000
Announcement Date 3/29/19 3/27/20 3/23/21 3/7/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 34.8 23.6 205 174 70.1 28.2
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) 1.241 x 0.3918 x 3.114 x 3.753 x 0.8158 x 0.3144 x
Free Cash Flow 1 -0.39 1.51 -10.3 40.7 32.9 47.7
ROE (net income / shareholders' equity) -3.42% 6.62% 5.58% 1.4% 12.1% 9.58%
ROA (Net income/ Total Assets) -2.34% 2.11% 2.24% 0.48% 3.11% 3.47%
Assets 1 638.5 1,484 1,371 1,254 2,251 1,803
Book Value Per Share 2 10.50 11.80 12.10 12.10 14.50 15.00
Cash Flow per Share 2 0.9500 1.250 1.260 1.850 3.400 2.930
Capex 1 15.5 14.7 39.4 27.2 26.2 27.5
Capex / Sales 4.33% 3.52% 8.5% 5.69% 4.61% 4.91%
Announcement Date 3/29/19 3/27/20 3/23/21 3/7/22 3/16/23 3/14/24
1TWD in Million2TWD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
YUNG ZIP CHEMICAL IND. CO., LTD. Stock Yung Zip Chemical Ind. Co., Ltd.
-10.20% 46.45M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 4102 Stock
  4. Financials Yung Zip Chemical Ind. Co., Ltd.